Top Insights
Korean biotech firm bought by Parataxis for Bitcoin treasury use
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Related Articles
Is the 4-Year Bitcoin Cycle Over? Rational Root Explains Why This Time Might Not Be Different
Bitcoin Magazine Is the 4-Year Bitcoin Cycle Over? Rational Root Explains Why...
Odds of SOL, LTC, XRP ETF approval stand at 95%: analysts
The chances of the U.S. Securities and Exchange Commission approving spot cryptocurrency...
US crypto ETF approval odds surge to ‘90% or higher’ — Bloomberg analysts
The SEC likely views cryptocurrencies Litecoin, Solana, XRP, Dogecoin, Cardano and others...
Crypto user attacked in France over Ledger hardware wallet — Report
The latest reported “wrench attack,” in which criminals targeted individuals for their...
Leave a comment